ABOUT US

HighCape is a growth equity fund with a unique, multidisciplinary team of savvy executives. With decades of business success, HighCape transforms outstanding medical technology companies into sustainable businesses.

founded

investments completed

employees

million annual revenue

Learn more

PORTFOLIO

Our portfolio size is intentionally small so we can dedicate the time and effort 
required to customize our investment strategy to address the specific needs of each company. Through these investments, we create scalable, revenue-generating 
entities with multiple exit alternatives.

TELA Bio
Aziyo Biologics
Wellinks
Zipline Medical
Cheetah Medical
Read more

CASE STUDIES

We are passionate about building companies and have a track record of success in delivering value to our investment partners and the healthcare system. See how our investment strategy has transformed companies and realized outsized returns.

Case Studies

LATEST NEWS

HighCape Capital Acquisition Corp. Announces Closing of $115 Million Initial Public Offering read more
HighCape Capital Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering read more
Wellinks has been awarded 2020 Venture of the Year from the CT Entrepreneur Awards read more
TELA Bio Announces Interim Analysis from BRAVO Study of OviTex® for Ventral Hernia Repair read more
title read more
See more articles

CONTACT US

Could HighCape be the right partner for your growing business?
Contact us for more information.

452 5th Ave, 21st Floor
New York, NY 10018